TY - JOUR T1 - INVEST: A phase Ib window of opportunity study of atezolizumab administered either intravesically or direct tumour injection in patients with bladder cancer prior to radical cystectomy. JO - Journal of Clinical Oncology UR - http://dx.doi.org/10.1200/jco.2024.42.4_suppl.tps710 PY - 2024/01/29 AU - Hussain SA AU - Oughton JB AU - Smith Whelan R AU - Green A AU - Hubbard R AU - Kennish S AU - Senior E AU - Kendall J AU - McCready D AU - Collinson FJ AU - Griffin J et al ED - DO - DOI: 10.1200/jco.2024.42.4_suppl.tps710 PB - American Society of Clinical Oncology (ASCO) VL - 42 IS - 4_suppl SP - TPS710 EP - TPS710 Y2 - 2025/07/28 ER -